Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis

2000 ◽  
Vol 22 (11) ◽  
pp. 1357-1369 ◽  
Author(s):  
Jennifer H. Lofland ◽  
Suzanne M. Touch ◽  
John P. O'Connor ◽  
Mary Lou Chatterton ◽  
Elizabeth D. Moxey ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
Cost Effectiveness ◽  
High Risk ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Syncytial Virus ◽  
High Risk Infants

scholarly journals Passive immunisation against respiratory syncytial virus: a cost-effectiveness analysis

2010 ◽  
Vol 95 (7) ◽  
pp. 493-498 ◽  
Author(s):  
E. Rietveld ◽  
E. W. Steyerberg ◽  
J. J. Polder ◽  
H. J. Veeze ◽  
Y. Vergouwe ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Passive Immunisation ◽  
Effectiveness Analysis ◽  
Syncytial Virus
Sign in / Sign up

Export Citation Format

Share Document